Gts Securities LLC Ocugen, Inc. Transaction History

Gts Securities LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$0.98 - $1.95 $22,968 - $45,702	-23,437 Reduced 38.64%	37,211 $36,000
Q2 2024 Aug 14, 2024	SELL	$1.18 - $1.98 $12,631 - $21,195	-10,705 Reduced 15.0%	60,648 $94,000
Q1 2024 May 15, 2024	BUY	$0.5 - $1.83 $30,215 - $110,586	60,430 Added 553.24%	71,353 $117,000
Q4 2023 Feb 14, 2024	BUY	$0.36 - $0.57 $3,932 - $6,226	10,923 New	10,923 $6,000

115

74.9M

200K

151K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $154M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.